1Sudon T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature,1988,322:78-81.
2Venugopal J. Cardiac natriuretic peptide-hope or hype? J Clinical Pharmacy Theraperutics, 2001,26:15-31.
3Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormaones in humans. Horm Metab Res,1999,31:487-498.
4Mair J, Friedl W, Thomas S, et al. Natriuretic peptides in assessment of left-ventricular dysfunction.Scand J Clin Invest, 1999,(Supple 230):132-142.
5Sagnella GA. Mearement and significance of circulating natriuretic peptides in cardiovascular disease. Clinical Science,1998,95:519-529.
6Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand,2001,171:395-403.
7Goto T, Takase H, Toriyama T, et al.Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart, 2003,89:1303-1307.
8Smith H, Picking R M,Struthers A, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ, 2000, 320:1.
9Ninuma H, Nakamura M, Hiramori K. Plasma B-type natriuretic peptide measurement in multiphasic health screening program. Cardiology,1998,90:89-94.
10Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation, 2003,108: 2964-2966.
